Vir Biotechnology (VIR) Change in Acquisitions & Divestments (2018 - 2025)
Vir Biotechnology's Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $342.9 million for Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments rose 13.88% to $342.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 30.91% decrease, with the full-year FY2025 number at $1.2 billion, down 30.91% from a year prior.
- Change in Acquisitions & Divestments hit $342.9 million in Q4 2025 for Vir Biotechnology, up from $305.2 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for VIR hit a ceiling of $715.7 million in Q4 2023 and a floor of $79.9 million in Q3 2021.
- Historically, Change in Acquisitions & Divestments has averaged $340.9 million across 5 years, with a median of $305.2 million in 2025.
- Biggest five-year swings in Change in Acquisitions & Divestments: surged 427.69% in 2023 and later crashed 57.93% in 2024.
- Tracing VIR's Change in Acquisitions & Divestments over 5 years: stood at $79.9 million in 2021, then surged by 233.92% to $266.7 million in 2022, then surged by 168.39% to $715.7 million in 2023, then plummeted by 57.93% to $301.1 million in 2024, then rose by 13.88% to $342.9 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for VIR at $342.9 million in Q4 2025, $305.2 million in Q3 2025, and $251.3 million in Q2 2025.